We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · July 14, 2021

Effectiveness and Treatment Retention of TNF Inhibitors When Used as Monotherapy vs Co-Medication With csDMARDs in Patients With Psoriatic Arthritis

Annals of the rheumatic diseases

 

Additional Info

Annals of the rheumatic diseases
Effectiveness and Treatment Retention of TNF Inhibitors When Used as Monotherapy Versus Comedication With csDMARDs in 15 332 Patients With Psoriatic Arthritis. Data From the EuroSpA Collaboration
Ann. Rheum. Dis 2021 Jun 03;[EPub Ahead of Print], U Lindström, D Di Giuseppe, B Delcoigne, B Glintborg, B Möller, A Ciurea, M Pombo-Suarez, C Sanchez-Piedra, K Eklund, H Relas, B Gudbjornsson, TJ Love, GT Jones, C Codreanu, R Ionescu, L Nekvindova, J Závada, N Atas, S Yolbas, KM Fagerli, B Michelsen, Ž Rotar, M Tomšič, F Iannone, MJ Santos, P Avila-Ribeiro, LM Ørnbjerg, M Østergaard, LT Jacobsson, J Askling, MJ Nissen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading